Showing results (531-540 of 552) with videos related to
Sort By:
Pageof 56
Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model ApproachAnjalika Nande, Soren L Larsen, James Turtle, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2025
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaborationMarco Ajelli, Jean-Jacques Muyembe, Alhassane Touré, et al.EPJ Data Science|December 20, 2016
Enhancing disease surveillance with novel data streams: challenges and opportunitiesBenjamin M Althouse, Samuel V Scarpino, Lauren Ancel Meyers, et al.Parasites & Vectors|April 24, 2025
Evaluation of the 2022 West Nile virus forecasting challenge, USARyan D Harp, Karen M Holcomb, Renata Retkute, et al.JAMA Network Open|September 18, 2025
Scenario Projections of COVID-19 Burden in the US, 2024-2025Sara L Loo, Sung-Mok Jung, Lucie Contamin, et al.Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Adaptive multi-model ensembles for improved epidemic projections and decision supportStefania Fiandrino, Daniela Paolotti, Clara Bay, et al.Nature Medicine|May 20, 2026
Global approaches to infectious disease surveillance and modelingMark P Khurana, Joseph L-H Tsui, Bernardo Gutierrez, et al.Elife|June 21, 2022
Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationShaun Truelove, Claire P Smith, Michelle Qin, et al.Medrxiv : the Preprint Server for Health Sciences|March 22, 2022
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studyRebecca K Borchering, Luke C Mullany, Emily Howerton, et al.Lancet Regional Health. Americas|November 28, 2022
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model studyRebecca K Borchering, Luke C Mullany, Emily Howerton, et al.Pageof 56